Groundbreaking Cold Plasma technology introduced in Oman
To commemorate the launch, a high-profile medical symposium was held in Muscat, drawing the participation of over 150 doctors and healthcare professionals from across the country. The event brought together leading experts from Europe and Oman for a full day of scientific exchange, practical insight, and a live demonstration of the device.
The Neoplas Argon Jet utilizes cold atmospheric argon plasma to accelerate wound healing, stimulate tissue regeneration, and inactivate pathogens — without pain or other side effects. Its use in treating diabetic foot ulcers, chronic wounds, dermatological lesions, and post-surgical infections has already shown remarkable results in clinical settings.
'This is more than a product launch; it's the beginning of a new chapter in how we approach wound care in Oman,' said Saju George, Managing Director of Alfarsi National Enterprises. 'The clinical success at top hospitals and the overwhelming interest from the medical community show just how timely and impactful this technology is.'
The Neoplas Argon Jet is the result of years of rigorous scientific collaboration involving neoplas med GmbH, the Leibniz Institute for Plasma Science and Technology (INP), University Medical Center Greifswald, Charité – Universitätsmedizin Berlin, and various research and industrial partners across Europe.
The symposium featured renowned speakers including Dr. Christian Seebauer, a pioneer in plasma-based wound care from Germany; Dr. Aleksandra Szlachcic, a Polish dermatologist with years of clinical experience in scar and dermatological treatments; and Prof. Dr. Ralf Lobmann, a leading diabetologist specializing in diabetic foot ulcers. Dr. Klaus Ruhnau, COO of Neoplas Med GmbH, also addressed the audience, highlighting the global momentum behind cold plasma therapy.
'This symposium brought science, practice, and future potential together in one place,' said Dr. Ruhnau. 'We were thrilled to see the level of engagement and curiosity from Oman's medical professionals.'
Throughout the day, attendees explored the underlying science of cold plasma, its medical and economic impact, and its potential to transform the treatment of complex wounds. Sessions highlighted growing global evidence for PlasmaJet technology and its applications in dermatology and infection control. The event also featured a live demonstration and hands-on experience, allowing participants to observe and practice using the system in a simulated clinical environment.
With its robust scientific backing, and growing international recognition, the Neoplas Argon Jet is now available in Oman — offering a safe, effective, and non-antibiotic treatment solution for some of the most challenging wound care cases in modern medicine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Observer
6 days ago
- Observer
India, Poland, Hungary make spaceflight comeback with ISS mission
CAPE CANAVERAL: A US commercial mission carrying crew from India, Poland and Hungary blasted off to the International Space Station on Wednesday, taking astronauts from these countries to space for the first time in decades. Axiom Mission 4, or Ax-4, launched from NASA's Kennedy Space Center in Florida at 2:31 am, with a brand-new SpaceX Crew Dragon capsule riding atop a Falcon 9 rocket. The vehicle is scheduled to dock with the orbital lab on Thursday at approximately 11:00 GMT and remain there for up to 14 days. Aboard the spacecraft were pilot Shubhanshu Shukla of India; mission specialists Slawosz Uznanski-Wisniewski of Poland and Tibor Kapu of Hungary; and commander Peggy Whitson of the United States, a former NASA astronaut who now works for the company Axiom Space, which organizes private spaceflights, among other things. The last time India, Poland or Hungary sent people to space, their current crop of astronauts had not yet been born — and back then they were called cosmonauts, as they all flew on Soviet missions before the fall of the Iron Curtain. Shukla became the first Indian in space since Rakesh Sharma, an air force pilot who traveled to the Salyut 7 space station in 1984 as part of a Soviet-led initiative to help allied countries access space. India's space agency, ISRO, sees this flight as a key stepping stone toward its own maiden crewed mission, planned for 2027 under the Gaganyaan programme, meaning "sky craft" in Hindi. Indian Prime Minister Narendra Modi hailed the successful launch of the Ax-4 space mission. "He (Shukla) carries with him the wishes, hopes and aspirations of 1.4 billion Indians. Wish him and other astronauts all the success!" he wrote on X. All three countries are footing the bill for their astronauts. Hungary announced in 2022 it was paying $100 million for its seat, according to India and Poland have not disclosed how much they are spending. "We've got this! Poland has reached for the stars," Polish Prime Minister Donald Tusk said on X, alongside a video himself watching the launch on a screen at the Copernicus Science Centre in Warsaw. "Who knows how many future Polish astronauts watched Slawosz's launch with me? Everyone was very excited and very proud," Tusk said in another post, which included a photo of him seated next to several children at the science centre. The Ax-4 launch comes after multiple issues delayed the mission, originally slated for early June. It also follows an explosive online spat between US President Donald Trump and SpaceX chief Elon Musk, the world's richest person and, until recently, Trump's ally and advisor. — AFP
Observer
23-06-2025
- Observer
Cold plasma technology introduced in Oman
Neoplas Argon Jet was launched after successful trials and a landmark symposium attended by over 150 healthcare professionals, including 80 Omani doctors specialising in infection control and paediatric surgery from hospitals under the Ministry of Health as well as from the private sector. A major advancement in wound care and infection management technology was celebrated at an event attended by top officials from the Ministry of Health with the official launch of the Neoplas Argon Jet Cold Plasma treatment in Oman. Oman has a 17 per cent increase in diabetic cases annually, prompting the medical community to explore innovative treatment methods. The CE MDR-approved German technology was introduced following successful clinical evaluations at Khoula Hospital and Oman International Hospital. To mark the launch organised by Alfarsi National Enterprises, a high-profile medical symposium was held in Muscat, drawing over 150 doctors and healthcare professionals from across the country. The event brought together leading experts from Europe and Oman for a full day of scientific exchange, practical insight, and a live demonstration of the device. Fatma al Adawi, a Podiatrist at Oman International Hospital, shared that the symposium was a valuable experience. The science behind cold plasma therapy shows promise, especially for chronic wound management. The groundbreaking Neoplas Argon Jet utilises cold atmospheric argon plasma to accelerate wound healing, stimulate tissue regeneration, and inactivate pathogens without pain or side effects. Its use in treating diabetic foot ulcers, chronic wounds, dermatological lesions and post-surgical infections has shown remarkable results in clinical settings at MoH hospitals. Saju George, Managing Director of Alfarsi National Enterprises, stated, "This launch of advanced technology for diabetic foot ulcers and road accident victims marks a new chapter in how we approach wound care in Oman." The Neoplas Argon Jet is the result of years of rigorous scientific collaboration involving neoplas med GmbH, the Leibniz Institute for Plasma Science and Technology (INP), University Medical Center Greifswald, Charité – Universitätsmedizin Berlin, and various research and industrial partners across Europe. The symposium featured renowned speakers including Dr Christian Seebauer, Dr Aleksandra Szlachcic, and Prof. Dr Ralf Lobmann, who shared their expertise in plasma-based wound care, dermatology, and diabetic foot ulcers, respectively. Dr Klaus Ruhnau, COO of Neoplas Med GmbH, also addressed the audience, highlighting the global momentum behind cold plasma therapy.
Muscat Daily
19-06-2025
- Muscat Daily
Groundbreaking Cold Plasma technology introduced in Oman
Muscat — A major leap in advanced wound care and infection management was marked this week with the official launch of the Neoplas Argon Jet Cold Plasma device in Oman. The CE MDR-approved German technology was introduced by Alfarsi National Enterprises following successful clinical evaluations at Khoula Hospital and Oman International Hospital. To commemorate the launch, a high-profile medical symposium was held in Muscat, drawing the participation of over 150 doctors and healthcare professionals from across the country. The event brought together leading experts from Europe and Oman for a full day of scientific exchange, practical insight, and a live demonstration of the device. The Neoplas Argon Jet utilizes cold atmospheric argon plasma to accelerate wound healing, stimulate tissue regeneration, and inactivate pathogens — without pain or other side effects. Its use in treating diabetic foot ulcers, chronic wounds, dermatological lesions, and post-surgical infections has already shown remarkable results in clinical settings. 'This is more than a product launch; it's the beginning of a new chapter in how we approach wound care in Oman,' said Saju George, Managing Director of Alfarsi National Enterprises. 'The clinical success at top hospitals and the overwhelming interest from the medical community show just how timely and impactful this technology is.' The Neoplas Argon Jet is the result of years of rigorous scientific collaboration involving neoplas med GmbH, the Leibniz Institute for Plasma Science and Technology (INP), University Medical Center Greifswald, Charité – Universitätsmedizin Berlin, and various research and industrial partners across Europe. The symposium featured renowned speakers including Dr. Christian Seebauer, a pioneer in plasma-based wound care from Germany; Dr. Aleksandra Szlachcic, a Polish dermatologist with years of clinical experience in scar and dermatological treatments; and Prof. Dr. Ralf Lobmann, a leading diabetologist specializing in diabetic foot ulcers. Dr. Klaus Ruhnau, COO of Neoplas Med GmbH, also addressed the audience, highlighting the global momentum behind cold plasma therapy. 'This symposium brought science, practice, and future potential together in one place,' said Dr. Ruhnau. 'We were thrilled to see the level of engagement and curiosity from Oman's medical professionals.' Throughout the day, attendees explored the underlying science of cold plasma, its medical and economic impact, and its potential to transform the treatment of complex wounds. Sessions highlighted growing global evidence for PlasmaJet technology and its applications in dermatology and infection control. The event also featured a live demonstration and hands-on experience, allowing participants to observe and practice using the system in a simulated clinical environment. With its robust scientific backing, and growing international recognition, the Neoplas Argon Jet is now available in Oman — offering a safe, effective, and non-antibiotic treatment solution for some of the most challenging wound care cases in modern medicine.
